Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045
MASLD poses a significant burden with notable gender and regional disparities. The projected increase by 2045 underscores the need for urgent public health interventions and targeted strategies to mitigate this growing epidemic.
Authors
- Na Huang (ORCID: https://orcid.org/0000-0001-7961-0677)
- Fang Han (ORCID: https://orcid.org/0000-0002-8743-8763)
- Chengxia Kan
- Ningning Hou (ORCID: https://orcid.org/0000-0002-3813-8465)
- Xiaodong Sun (ORCID: https://orcid.org/0000-0001-7775-2823)
- Chang Liu (ORCID: https://orcid.org/0000-0003-0776-6984)
- Yanhui Ma (ORCID: https://orcid.org/0000-0002-6465-974X)
- Xiaofei Zhang (ORCID: https://orcid.org/0000-0001-6765-8411)
- Kexin Zhang (ORCID: https://orcid.org/0000-0002-9224-9465)
- Yuqun Wang (ORCID: https://orcid.org/0000-0002-7380-3803)
Institutions
- Weifang Medical University (CN)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1016/j.aohep.2025.101898
- Citations
- 33
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 44.69
Funders
- Bill and Melinda Gates Foundation
- National Natural Science Foundation of China
- Taishan Scholar Project of Shandong Province